Clin2
NCT07451886Possibly a fitRecruiting

Fludrocortisone for septic shock

SepsisSeptic ShockSepsis - to Reduce Mortality in the Intensive Care UnitSepsis and Septic ShockSepsis at Intensive Care Unit

Treatments studied

Part of Infections clinical trials.

This study tests whether adding a steroid called fludrocortisone to standard care helps people with septic shock (a dangerous drop in blood pressure from infection) get better faster. If you are in the ICU, on a breathing machine, and need strong medication for your blood pressure, you may be eligible.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
32 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • You have sepsis (a severe infection affecting your whole body) and your blood pressure is very low despite treatment.
  • The low blood pressure started within the last 24 hours.
  • You are on a strong drip medication to keep your blood pressure up (like norepinephrine) for at least one hour.
  • You are on a breathing machine (ventilator).
  • You are not pregnant, and you do not have any condition that would prevent you from taking the study drug (like a severe allergy or a terminal illness).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07383103Recruiting· Phase 4
Steroid combination for septic shock

This trial tests whether two medicines (hydrocortisone and fludrocortisone) can help people with severe infections that cause dangerously low blood pressure (septic shock). It's for patients who have just been diagnosed and haven't used steroids recently.

Yangzhou, Jiangsu
NCT04280497Recruiting
Testing fast ways to tell steroid-resistant sepsis from sensitive

This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.

Garches, Hauts-de-Seine
NCT06723626Recruiting
Recovery blend for elderly sepsis patients

This study tests whether giving a special combination of hydrocortisone, vitamin C, and vitamin B1 helps older adults with sepsis recover better. It looks at how the treatment affects tiny blood vessels and overall survival.

Nanjing, Jiangsu
NCT03401398Recruiting· Phase 3
Hydrocortisone for children with septic shock in the ICU

This Phase 3 trial tests whether giving stress-dose hydrocortisone can improve outcomes for children with septic shock in the pediatric intensive care unit (PICU). It is designed for children who are already receiving strong medicines to support blood pressure because of a serious infection.

Tucson, Arizona
NCT07511582Recruiting· Phase 2
Steroids for severe breathing problems in the ICU

This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.

Beijing, Beijing Municipality
NCT06140147Recruiting
Reducing fluids in septic shock care

This study tests if giving fewer fluids (other than the fluids to keep blood pressure up) can help people recover from septic shock. It compares a reduced fluid strategy to the usual care in the ICU.

Helsinki

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.